Literature DB >> 6966608

Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues.

J Hamuro, M Röllinghoff, H Wagner.   

Abstract

Eight distinct polysaccharides (PS) of beta(1 leads to 3) glucan type were tested for their capacity to render murine peritoneal exudate cells (PEC) cytotoxic. After intraperitoneal injection of lentinan, pachymaran and HE-pachyman 3 and 4 highly cytotoxic PEC were induced. Pachyman and HE-pachyman 1 and 2 were of moderate effect, whereas CM-pachymaran and HE-pachyman 3 and 4, highly cytotoxic PEC were induced. Pachyman and HE-pachymacrophages. The induction of PEC-dependent cytotoxicity exhibited a strict dose relationship. Optimal administration of PS resulted in the induction of cytotoxicity, which persisted for more than 25 days. Surprisingly, none of the PS tested was capable of rendering normal or thioglycollate-induced PEC cytoxic under in vitro conditions. It is suggested that the capacity of PS to render in vivo macrophages cytotoxic is related to the potency of these PS to activate the alternative pathway of complement system (APC) in so far as C3b may be the essential component required to render macrophages cytotoxic.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966608      PMCID: PMC1458028     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments.

Authors:  G H Christie; R Bomford
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

2.  Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

Authors:  W F Piessens; W H Churchill
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Beta (1-3) glucans as a probe for T cell specific immune adjuvants. II. Enhanced in vitro generation of cytotoxic T lymphocytes.

Authors:  J Hamuro; H Wagner; M Röllinghoff
Journal:  Cell Immunol       Date:  1978-07       Impact factor: 4.868

4.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

5.  Carboxymethylpachymaran, a new water soluble polysaccharide with marked antitumour activity.

Authors:  J Hamuro; Y Yamashita; Y Ohsaka; Y Y Maeda; G Chihara
Journal:  Nature       Date:  1971-10-15       Impact factor: 49.962

6.  Periodical consideration on the establishment of antitumor action in host and activation of peritoneal exudate cells by lentinan.

Authors:  Y Y Maeda; G Chihara
Journal:  Gan       Date:  1973-08

7.  Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) sing.

Authors:  G Chihara; Y Maeda; J Hamuro; T Sasaki; F Fukuoka
Journal:  Nature       Date:  1969-05-17       Impact factor: 49.962

8.  Functional and morphologic characteristics of interferon-treated macrophages.

Authors:  R M Schultz; M A Chirigos; U I Heine
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

9.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

10.  T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia.

Authors:  H Wagner; A Starzinski-Powitz; M Röllinghoff; P Golstein; H Jakob
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  11 in total

1.  Immune-stimulating properties of polysaccharides from Phellodendri cortex (Hwangbek).

Authors:  J I Park; J K Shim; J W Do; S Y Kim; E K Seo; H J Kwon; T K Lee; J K Kim; D Y Choi; C H Kim
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

2.  Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases.

Authors:  K Yamasaki; S Sone; T Yamashita; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  The effect of lentinan on the resistance of mice to Mesocestoides corti.

Authors:  T R White; R C Thompson; W J Penhale; G Chihara
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

4.  Two genes controlling acute phase responses by the antitumor polysacch aride, lentinan.

Authors:  Y Y Maeda; S Takahama; Y Kohara; H Yonekawa
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Production of thymocyte-stimulating activity by cultured human thyroid epithelial cells.

Authors:  W Hirose; M Kawagoe; M Hara; A Kitani; T Hirose; K Norioka; M Harigai; H Nakamura
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

6.  Activation of mouse peritoneal macrophages by synthetic glyceroglycolipid liposomes.

Authors:  M Naito; I Kudo; Y Mukai-Sato; S Tsushima; H Nomura; S Nojima; K Inoue
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells.

Authors:  A Ladányi; J Tímár; K Lapis
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

8.  Polysaccharide from Lentinus edodes inhibits the immunosuppressive function of myeloid-derived suppressor cells.

Authors:  Hao Wu; Ning Tao; Xiaoman Liu; Xiao Li; Jian Tang; Chungwah Ma; Xiaofei Xu; Haitao Shao; Baidong Hou; Hui Wang; Zhihai Qin
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

9.  Immunostimulation-Mediated Anti-tumor Activity of Bamboo (Sasa senanensis) Leaf Extracts Obtained Under 'Vigorous' Condition.

Authors:  Takahiro Seki; Kenji Kida; Hiroshi Maeda
Journal:  Evid Based Complement Alternat Med       Date:  2008-05-07       Impact factor: 2.629

Review 10.  The use of lentinan for treating gastric cancer.

Authors:  Kenji Ina; Takae Kataoka; Takafumi Ando
Journal:  Anticancer Agents Med Chem       Date:  2013-06       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.